Past Indiscretions Haunt Novartis and Japan’s Clinical Trials Industry
This article was originally published in PharmAsia News
Executive Summary
Now prosecutors have laid charges against Novartis Pharma KK in Japan for manipulating data and making false claims about its Diovan hypertension drug, its reputation and the status of Japan’s clinical trials face further investigation.